FDA Inspection 1080056 — Zhejiang Xianju Junye Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Xianju Junye Pharmaceutical Co., Ltd. on January 11, 2019 in Taizhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 11, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou (China)